NCT05759728 2026-01-13A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal CancerCarina Biotech LimitedPhase 1/2 Recruiting45 enrolled
NCT06008119 2025-09-18Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal CancerShanghai Kechow Pharma, Inc.Phase 3 Recruiting165 enrolled